November 20, 2024

Genetic GERD Linked to Cardiovascular, Hypertension Risks

Genetically predicted gastroesophageal reflux disease may significantly increase the risk of myocardial infarction and hypertension.

Conexiant

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

Does Blood Pressure Variability Affect Visual Field Loss in Glaucoma?

Higher mean BP and higher BP variability were associated with faster VF deterioration.

Conexiant

November 19, 2024

Predicting ICH Causes: MRI Advantage

Conexiant

November 19, 2024

Are IV Alternatives the New Standard?

KFF Health News

November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Lilly Pill Lowers Lp(a) Up to 86%: Study

Reuters

November 18, 2024

Diabetes, Amyloid-β Interaction Doubles MCI Risk

Managing diabetes may reduce Alzheimer’s risk, as 20-year data reveal synergistic brain changes from diabetes and amyloid-β abnormality.

Conexiant

November 18, 2024

Skin Disease Signals Hidden Heart Risks

Psoriasis not only marks the skin but also significantly raises the risk of myocardial infarction, stroke, and cardiovascular death, highlighting an urgent need for cardiovascular screening in these patients.

Conexiant